An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: The identification of an early biomarker for autism spectrum disorder (ASD) would improve the determination of risk, leading to earlier diagnosis and, potentially to earlier intervention and improved outcomes. Methods: Data were generated from the Early Markers for Autism (EMA) study, a population-based case-control study of prenatal and neonatal biomarkers of ASD. Newborn bloodspots of children with ASD (N=370), developmental delay (DD, N=140), and general population (GP, N=378) controls were analyzed for 42 different immune markers using a Luminex multiplex platform. Comparisons of immune marker concentrations between groups were examined using logistic regression and Partial Least Squares Discriminant Analysis. Results: Children with ASD had significantly increased neonatal levels of IL-6 and IL-8 compared to GP controls. An increase in IL-8 was especially significant in the ASD group with early onset compared to the GP group with an adjusted odds ratio of 1.97 (95%CI 1.39–2.83 p=0.00014). In addition, children with ASD had significantly elevated levels of Eotaxin-1, IFN-γ, and IL-12p70 relative to children with developmental delay (DD). We observed no significant differences in levels of immune markers between the DD and GP groups. Conclusion: Elevated levels of some inflammatory markers in newborn bloodspots indicated a higher degree of immune activation at birth in children who were subsequently diagnosed with ASD. The data from this exploratory study suggest that with further expansion, the development of neonatal bloodspot testing for cytokine/chemokine levels might lead to the identification of biomarkers that provide an accurate assessment of ASD risk at birth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763 · cited 1×
“While activation of the immune system is classically associated with defense against invading pathogens, there is now evidence that the immune system plays a significant role in neurodevelopment (8) and in the regulation of neural plasticity throughout life (9, 10).”
BackgroundPrevalence of Autism Spectrum Disorders in a Total Population Sample
Kim, Y. S., Leventhal, B. L., Koh, Y.-J., Fombonne, E., Laska, E., Lim, E.-C., Cheon, K.-A., Kim, S.-J., Kim, Y.-K., Lee, H., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10101532 · Cited by 1,524
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248 · cited 2×
“Diagnostic Validation: For children identified from DDS/RC as ASD or DD, medical record abstractors compiled detailed diagnostic and clinical data from the RC records according to a protocol developed by the Metropolitan Atlanta Developmental Disabilities Surveillance Program (23).”
MethodMost genetic risk for autism resides with common variation
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., Mahajan, M., Manaa, D., Pawitan, Y., Reichert, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3039 · Cited by 1,239 · cited 1×
“While a number of genetic risk factors have been identified for ASD, recent evidence has shown that little more than half of the risk for developing ASD can be attributed to genetic mutations, and over 40% of risk is likely due to unknown environmental factors (5, 6).”
BackgroundSandin, S., Lichtenstein, P., Kuja-Halkola, R., Larsson, H., Hultman, C. M., & Reichenberg, A. (2014) · JAMA · doi:10.1001/jama.2014.4144 · Cited by 1,073
Microglia Regulate the Number of Neural Precursor Cells in the Developing Cerebral Cortex
Cunningham, C. L., Martínez-Cerdeño, V., & Noctor, S. C. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3441-12.2013 · Cited by 976 · cited 1×
“While activation of the immune system is classically associated with defense against invading pathogens, there is now evidence that the immune system plays a significant role in neurodevelopment (8) and in the regulation of neural plasticity throughout life (9, 10).”
BackgroundAshwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
Self-citationPrevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007
Kogan, M. D., Blumberg, S. J., Schieve, L. A., Boyle, C. A., Perrin, J. M., Ghandour, R. M., Singh, G. K., Strickland, B. B., Trevathan, E., & van Dyck, P. C. (2009) · Pediatrics · doi:10.1542/peds.2009-1522 · Cited by 892
Dawson, G., Jones, E. J. H., Merkle, K., Venema, K., Lowy, R., Faja, S., Kamara, D., Murias, M., Greenson, J., Winter, J., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.018 · Cited by 799 · cited 1×
“The most effective treatment currently available is behavioral intervention, and its success depends upon initiating treatment as early as possible (19).”
BackgroundThe Role of the Immune System in Autism Spectrum Disorder
Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533 · cited 1×
“Differences in circulating cytokine/ chemokine levels are amongst the most commonly reported immune abnormalities in individuals already diagnosed with ASD (13, 14).”
Background
Cited by
Maternal immune activation and neuroinflammation in human neurodevelopmental disorders
Han, V. X., Patel, S., Jones, H. F., & Dale, R. C. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00530-8 · Cited by 683
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Jiang, C.-C., Lin, L.-S., Long, S., Ke, X.-Y., Fukunaga, K., Lu, Y.-M., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 258
A Meta-analysis of Gut Microbiota in Children with Autism
Andreo-Martínez, P., Rubio-Aparicio, M., Sánchez-Meca, J., Veas, A., & Martínez-González, A. E. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05002-y · Cited by 96
“Epigenetic transcriptional factors, metabolites (propionic acid or PPA; short chain fatty acids or SCFAs), lipid and mitochondrial metabolism, and gaseous molecules, ion channel/gap junction/transporter regulation protein, and post-translational modification have also been analyzed (Heuer et al. 2019).”
BackgroundBennett (2023) · doi:10.1097/yco.0000000000000775 · Cited by 51
Metadata
- Authors
- Heuer, L. S., Croen, L. A., Jones, K. L., Yoshida, C. K., Hansen, R. L., Yolken, R., Zerbo, O., DeLorenze, G., Kharrazi, M., Ashwood, P., & Van de Water, J.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 86
- Issue
- 4
- Pages
- 255-264
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2946731554
- Cited by
- 101
- References
- 17
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study. https://app.cochat.ai/papers/10.1016/j.biopsych.2019.04.037
- The paper
- Heuer, L. S., Croen, L. A., Jones, K. L., Yoshida, C. K., Hansen, R. L., Yolken, R., Zerbo, O., DeLorenze, G., Kharrazi, M., Ashwood, P., & Van de Water, J. (2019). An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2019.04.037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.